Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Abstract Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has emerged as a distinct clinical entity within the spectrum of central nervous system inflammatory demyelinating disorders. Recent advances have refined its nosological classification, distinguishing it from both multiple sclerosis and a...